Beigene Co. Ltd., of Beijing, appointed Howard Liang chief financial officer and chief strategy officer. Liang has more than 20 years of combined experience on Wall Street as an analyst covering the biotechnology and pharmaceutical sectors and as a scientist in the biopharmaceutical industry.